FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2114449557> ?p ?o ?g. }

• W2114449557 abstract "To determine the efficacy of multimodality biologic response therapy for patients with cutaneous T-cell lymphoma (CTCL).Retrospective cohort study over a 14-year period.Tertiary care university hospital.A consecutive sample of patients was studied, all 47 of whom carried the clinical and laboratory diagnosis of CTCL: 68% of patients had stage III or IV disease, and 89% had circulating malignant T cells.All 47 patients received photopheresis for 6 or more cycles. Thirty-one patients received treatment with a combination of photopheresis and 1 or more systemic immunostimulatory agents, including interferon alfa, interferon gamma, sargramostim, or systemic retinoids for 3 or more months.Differences in pretreatment prognostic factors, response rates, and survival between patients receiving multimodality therapy and single-modality therapy or historical controls.A total of 79% of patients responded to therapy: 26% had complete remission, and 53% had a partial remission. Median survival from initiation of therapy was 74 months. Median survival for patients with stages III and IV and peripheral blood involvement was 55 months compared with 31 months for historical controls. Compared with the photopheresis monotherapy group, the patients receiving combination immunomodulatory therapy had a worse prognosis at the time of treatment initiation based on multiple prognostic factors. The positive response rates and median survival times were 84% and 74 months, respectively, compared with 75% and 66 months, respectively, for the combination immunomodulatory and photopheresis monotherapy groups (P =.47 for positive response rates and P =.51 for survival).Patients with advanced CTCL and multiple poor prognostic factors who receive treatment with combination immunomodulatory therapy experience higher clinical response rates and longer survival than historical controls. Although the group who received combination therapy had worse prognostic factors at baseline, they had better response rates and overall survival compared with those receiving photopheresis monotherapy." @default.
• W2114449557 created "2016-06-24" @default.
• W2114449557 creator A5000496404 @default.
• W2114449557 creator A5006018976 @default.
• W2114449557 creator A5021690954 @default.
• W2114449557 creator A5033787859 @default.
• W2114449557 creator A5054257908 @default.
• W2114449557 creator A5061211377 @default.
• W2114449557 creator A5067235495 @default.
• W2114449557 creator A5074635551 @default.
• W2114449557 creator A5079358097 @default.
• W2114449557 date "2002-08-01" @default.
• W2114449557 modified "2023-10-17" @default.
• W2114449557 title "Treatment of Cutaneous T-Cell Lymphoma With Combined Immunomodulatory Therapy" @default.
• W2114449557 cites W1223669674 @default.
• W2114449557 cites W1566680641 @default.
• W2114449557 cites W176755457 @default.
• W2114449557 cites W1880480935 @default.
• W2114449557 cites W1967780087 @default.
• W2114449557 cites W1972845462 @default.
• W2114449557 cites W1995494112 @default.
• W2114449557 cites W2001842364 @default.
• W2114449557 cites W2008459543 @default.
• W2114449557 cites W2017846085 @default.
• W2114449557 cites W2018902160 @default.
• W2114449557 cites W2024594863 @default.
• W2114449557 cites W2029117355 @default.
• W2114449557 cites W2031254710 @default.
• W2114449557 cites W2044158364 @default.
• W2114449557 cites W2053897064 @default.
• W2114449557 cites W2054891514 @default.
• W2114449557 cites W2078277756 @default.
• W2114449557 cites W2079447575 @default.
• W2114449557 cites W2085249569 @default.
• W2114449557 cites W2088303434 @default.
• W2114449557 cites W2092612480 @default.
• W2114449557 cites W2093163019 @default.
• W2114449557 cites W2096843411 @default.
• W2114449557 cites W2128568150 @default.
• W2114449557 cites W2153253124 @default.
• W2114449557 cites W2156741473 @default.
• W2114449557 cites W2337557724 @default.
• W2114449557 cites W2411622527 @default.
• W2114449557 cites W2415166681 @default.
• W2114449557 cites W2473215883 @default.
• W2114449557 cites W2685902892 @default.
• W2114449557 doi "https://doi.org/10.1001/archderm.138.8.1054" @default.
• W2114449557 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12164743" @default.
• W2114449557 hasPublicationYear "2002" @default.
• W2114449557 type Work @default.
• W2114449557 sameAs 2114449557 @default.
• W2114449557 citedByCount "106" @default.
• W2114449557 countsByYear W21144495572012 @default.
• W2114449557 countsByYear W21144495572013 @default.
• W2114449557 countsByYear W21144495572014 @default.
• W2114449557 countsByYear W21144495572015 @default.
• W2114449557 countsByYear W21144495572016 @default.
• W2114449557 countsByYear W21144495572017 @default.
• W2114449557 countsByYear W21144495572018 @default.
• W2114449557 countsByYear W21144495572019 @default.
• W2114449557 countsByYear W21144495572020 @default.
• W2114449557 countsByYear W21144495572021 @default.
• W2114449557 countsByYear W21144495572022 @default.
• W2114449557 countsByYear W21144495572023 @default.
• W2114449557 crossrefType "journal-article" @default.
• W2114449557 hasAuthorship W2114449557A5000496404 @default.
• W2114449557 hasAuthorship W2114449557A5006018976 @default.
• W2114449557 hasAuthorship W2114449557A5021690954 @default.
• W2114449557 hasAuthorship W2114449557A5033787859 @default.
• W2114449557 hasAuthorship W2114449557A5054257908 @default.
• W2114449557 hasAuthorship W2114449557A5061211377 @default.
• W2114449557 hasAuthorship W2114449557A5067235495 @default.
• W2114449557 hasAuthorship W2114449557A5074635551 @default.
• W2114449557 hasAuthorship W2114449557A5079358097 @default.
• W2114449557 hasBestOaLocation W21144495571 @default.
• W2114449557 hasConcept C126322002 @default.
• W2114449557 hasConcept C141071460 @default.
• W2114449557 hasConcept C146357865 @default.
• W2114449557 hasConcept C151730666 @default.
• W2114449557 hasConcept C167135981 @default.
• W2114449557 hasConcept C203014093 @default.
• W2114449557 hasConcept C2776090121 @default.
• W2114449557 hasConcept C2776780870 @default.
• W2114449557 hasConcept C2776999253 @default.
• W2114449557 hasConcept C2777756187 @default.
• W2114449557 hasConcept C2777891184 @default.
• W2114449557 hasConcept C2779338263 @default.
• W2114449557 hasConcept C2781468836 @default.
• W2114449557 hasConcept C71924100 @default.
• W2114449557 hasConcept C86803240 @default.
• W2114449557 hasConcept C8891405 @default.
• W2114449557 hasConcept C90924648 @default.
• W2114449557 hasConceptScore W2114449557C126322002 @default.
• W2114449557 hasConceptScore W2114449557C141071460 @default.
• W2114449557 hasConceptScore W2114449557C146357865 @default.
• W2114449557 hasConceptScore W2114449557C151730666 @default.
• W2114449557 hasConceptScore W2114449557C167135981 @default.
• W2114449557 hasConceptScore W2114449557C203014093 @default.
• W2114449557 hasConceptScore W2114449557C2776090121 @default.
• W2114449557 hasConceptScore W2114449557C2776780870 @default.

• next